These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19112176)

  • 21. Ubiquitin-Binding Protein CG5445 Suppresses Aggregation and Cytotoxicity of Amyotrophic Lateral Sclerosis-Linked TDP-43 in Drosophila.
    Uechi H; Kuranaga E; Iriki T; Takano K; Hirayama S; Miura M; Hamazaki J; Murata S
    Mol Cell Biol; 2018 Feb; 38(3):. PubMed ID: 29109084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions].
    Kasahara S; Ishihara T; Koike Y; Sugai A; Onodera O
    Rinsho Shinkeigaku; 2020 Feb; 60(2):109-116. PubMed ID: 31956195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.
    Saxton AD; Kraemer BC
    G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of Linear Ubiquitination Ameliorates Cytoplasmic Aggregation of Truncated TDP-43.
    Zhang Q; Terawaki S; Oikawa D; Okina Y; Usuki Y; Ito H; Tokunaga F
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal Expression of UBQLN2
    Picher-Martel V; Renaud L; Bareil C; Julien JP
    Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis.
    Chen HJ; Mitchell JC; Novoselov S; Miller J; Nishimura AL; Scotter EL; Vance CA; Cheetham ME; Shaw CE
    Brain; 2016 May; 139(Pt 5):1417-32. PubMed ID: 26936937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines.
    Cassel JA; Reitz AB
    Biochim Biophys Acta; 2013 Jun; 1834(6):964-71. PubMed ID: 23541532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43.
    Caccamo A; Shaw DM; Guarino F; Messina A; Walker AW; Oddo S
    Hum Mol Genet; 2015 Aug; 24(16):4625-35. PubMed ID: 26002100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
    Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
    Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration.
    Zhang KY; Yang S; Warraich ST; Blair IP
    Int J Biochem Cell Biol; 2014 May; 50():123-6. PubMed ID: 24589709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43.
    Urushitani M; Sato T; Bamba H; Hisa Y; Tooyama I
    J Neurosci Res; 2010 Mar; 88(4):784-97. PubMed ID: 19798749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
    Shen WC; Li HY; Chen GC; Chern Y; Tu PH
    Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells.
    Picher-Martel V; Dutta K; Phaneuf D; Sobue G; Julien JP
    Mol Brain; 2015 Oct; 8(1):71. PubMed ID: 26521126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels.
    Prtenjaca N; Rob M; Alam MS; Markovinovic A; Stuani C; Buratti E; Munitic I
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.
    Wang X; Zhou S; Ding X; Ma M; Zhang J; Zhou Y; Wu E; Teng J
    Int J Biol Sci; 2015; 11(10):1140-9. PubMed ID: 26327808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization.
    Lee JE; Jeon IS; Han NE; Song HJ; Kim EG; Choi JW; Song KD; Lee HK; Choi JK
    Mol Cells; 2013 Jan; 35(1):41-6. PubMed ID: 23307288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
    Hergesheimer RC; Chami AA; de Assis DR; Vourc'h P; Andres CR; Corcia P; Lanznaster D; Blasco H
    Brain; 2019 May; 142(5):1176-1194. PubMed ID: 30938443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.